combiso comprimate 10 mg + 6,25 mg
pro.med.cs praha a.s. - bisoprololum + hydrochlorothiazidum - comprimate - 10 mg + 6,25 mg
combiso comprimate 2,5 mg + 6,25 mg
pro.med.cs praha a.s. - bisoprololum + hydrochlorothiazidum - comprimate - 2,5 mg + 6,25 mg
combiso comprimate 5 mg + 6,25 mg
pro.med.cs praha a.s. - bisoprololum + hydrochlorothiazidum - comprimate - 5 mg + 6,25 mg
vaccin contra bursitei infecţioase avivac-ibb, pastilă liofilizată
avivac, rusia - tulpina - pulbere liofilizată
opdualag
bristol-myers squibb pharma eeig - nivolumab, relatlimab - melanomul - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.
sotyktu
bristol-myers squibb pharma eeig - deucravacitinib - psoriazis - imunosupresoare - treatment of moderate-to-severe plaque psoriasis in adults.
hydrea 500 mg
latina pharma s.p.a. - italia - hydroxycarbamidum - caps. - 500mg - alte antineoplazice alte antineoplazice
efferalgan supozitoare 300 mg
bristol-myers squibb - supozitoare - 300 mg
efferalgan supozitoare 150 mg
bristol-myers squibb - supozitoare - 150 mg
efferalgan supozitoare 80 mg
bristol-myers squibb - supozitoare - 80 mg